The Bio-Synthetic Unification: A Topological Approach to the Pharmaceutical Sweet Spot

We present a deterministic framework for drug discovery that unifies biological efficacy and synthetic accessibility into a single topological metric: the Unified Score (US). By modeling molecules as spectral graphs and minimizing their "Synthetic Entropy" (derived from the Laplacian Fiedler vector), the algorithm autonomously rediscovered Imatinib (Gleevec) as an optimal "blockbuster" candidate in a blind retro-validation study. This work demonstrates that pharmaceutical success is a function of thermodynamic modularity encoded in the molecular graph, effectively filtering out "academic traps" and unmanufacturable targets.